Cargando…

C-reactive protein does not predict future depression onset in adolescents: preliminary findings from a longitudinal study

INTRODUCTION: Neuroinflammatory processes have been extensively implicated in the underlying neurobiology of numerous neuropsychiatric disorders. Elevated C-reactive protein (CRP), an indicator of non-specific inflammation commonly utilized in clinical practice, has been associated with depression i...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Joshua J., Roske, Chloe, Liu, Qi, Tobe, Russel H., Ely, Benjamin A., Gabbay, Vilma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635217/
https://www.ncbi.nlm.nih.gov/pubmed/37961448
http://dx.doi.org/10.1101/2023.10.26.23297634
_version_ 1785146306214232064
author Schwartz, Joshua J.
Roske, Chloe
Liu, Qi
Tobe, Russel H.
Ely, Benjamin A.
Gabbay, Vilma
author_facet Schwartz, Joshua J.
Roske, Chloe
Liu, Qi
Tobe, Russel H.
Ely, Benjamin A.
Gabbay, Vilma
author_sort Schwartz, Joshua J.
collection PubMed
description INTRODUCTION: Neuroinflammatory processes have been extensively implicated in the underlying neurobiology of numerous neuropsychiatric disorders. Elevated C-reactive protein (CRP), an indicator of non-specific inflammation commonly utilized in clinical practice, has been associated with depression in adults. In adolescents, our group previously found CRP to be associated with altered neural reward function but not with mood and anxiety symptoms assessed cross-sectionally. We hypothesized that the distinct CRP findings in adolescent vs. adult depression may be due to chronicity, with neuroinflammatory effects on psychiatric disorders gradually accumulating over time. Here, we conducted a longitudinal study to evaluate if CRP levels predicted future onset or progression of depression in adolescents. METHODS: Participants were 53 adolescents (ages 14.74 ± 1.92, 35 female), 40 with psychiatric symptoms and 13 healthy controls. At baseline, participants completed semi-structured diagnostic evaluations; dimensional assessments for anxiety, depression, anhedonia, and suicidality severity; and bloodwork to quantify CRP levels. Clinical assessments were repeated at longitudinal follow-up after approximately 1.5 years. Spearman’s correlation between CRP levels and follow-up symptom severity were controlled for BMI, age, sex, and follow-up interval and considered significant at the two-tailed, Bonferroni-adjusted p < 0.05 level. RESULTS: After correction for multiple comparisons, no relationships were identified between baseline CRP levels and follow-up symptom severity. CONCLUSION: CRP levels were not significantly associated with future psychiatric symptoms in adolescents in this preliminary analysis. This may suggest that CRP is not a useful biomarker for adolescent depression and anxiety. However, future longitudinal studies with larger sample sizes and incorporating additional indicators of neuroinflammation are needed.
format Online
Article
Text
id pubmed-10635217
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-106352172023-11-13 C-reactive protein does not predict future depression onset in adolescents: preliminary findings from a longitudinal study Schwartz, Joshua J. Roske, Chloe Liu, Qi Tobe, Russel H. Ely, Benjamin A. Gabbay, Vilma medRxiv Article INTRODUCTION: Neuroinflammatory processes have been extensively implicated in the underlying neurobiology of numerous neuropsychiatric disorders. Elevated C-reactive protein (CRP), an indicator of non-specific inflammation commonly utilized in clinical practice, has been associated with depression in adults. In adolescents, our group previously found CRP to be associated with altered neural reward function but not with mood and anxiety symptoms assessed cross-sectionally. We hypothesized that the distinct CRP findings in adolescent vs. adult depression may be due to chronicity, with neuroinflammatory effects on psychiatric disorders gradually accumulating over time. Here, we conducted a longitudinal study to evaluate if CRP levels predicted future onset or progression of depression in adolescents. METHODS: Participants were 53 adolescents (ages 14.74 ± 1.92, 35 female), 40 with psychiatric symptoms and 13 healthy controls. At baseline, participants completed semi-structured diagnostic evaluations; dimensional assessments for anxiety, depression, anhedonia, and suicidality severity; and bloodwork to quantify CRP levels. Clinical assessments were repeated at longitudinal follow-up after approximately 1.5 years. Spearman’s correlation between CRP levels and follow-up symptom severity were controlled for BMI, age, sex, and follow-up interval and considered significant at the two-tailed, Bonferroni-adjusted p < 0.05 level. RESULTS: After correction for multiple comparisons, no relationships were identified between baseline CRP levels and follow-up symptom severity. CONCLUSION: CRP levels were not significantly associated with future psychiatric symptoms in adolescents in this preliminary analysis. This may suggest that CRP is not a useful biomarker for adolescent depression and anxiety. However, future longitudinal studies with larger sample sizes and incorporating additional indicators of neuroinflammation are needed. Cold Spring Harbor Laboratory 2023-10-27 /pmc/articles/PMC10635217/ /pubmed/37961448 http://dx.doi.org/10.1101/2023.10.26.23297634 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Schwartz, Joshua J.
Roske, Chloe
Liu, Qi
Tobe, Russel H.
Ely, Benjamin A.
Gabbay, Vilma
C-reactive protein does not predict future depression onset in adolescents: preliminary findings from a longitudinal study
title C-reactive protein does not predict future depression onset in adolescents: preliminary findings from a longitudinal study
title_full C-reactive protein does not predict future depression onset in adolescents: preliminary findings from a longitudinal study
title_fullStr C-reactive protein does not predict future depression onset in adolescents: preliminary findings from a longitudinal study
title_full_unstemmed C-reactive protein does not predict future depression onset in adolescents: preliminary findings from a longitudinal study
title_short C-reactive protein does not predict future depression onset in adolescents: preliminary findings from a longitudinal study
title_sort c-reactive protein does not predict future depression onset in adolescents: preliminary findings from a longitudinal study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635217/
https://www.ncbi.nlm.nih.gov/pubmed/37961448
http://dx.doi.org/10.1101/2023.10.26.23297634
work_keys_str_mv AT schwartzjoshuaj creactiveproteindoesnotpredictfuturedepressiononsetinadolescentspreliminaryfindingsfromalongitudinalstudy
AT roskechloe creactiveproteindoesnotpredictfuturedepressiononsetinadolescentspreliminaryfindingsfromalongitudinalstudy
AT liuqi creactiveproteindoesnotpredictfuturedepressiononsetinadolescentspreliminaryfindingsfromalongitudinalstudy
AT toberusselh creactiveproteindoesnotpredictfuturedepressiononsetinadolescentspreliminaryfindingsfromalongitudinalstudy
AT elybenjamina creactiveproteindoesnotpredictfuturedepressiononsetinadolescentspreliminaryfindingsfromalongitudinalstudy
AT gabbayvilma creactiveproteindoesnotpredictfuturedepressiononsetinadolescentspreliminaryfindingsfromalongitudinalstudy